Fisetin Safety Profile: Side Effects, Drug Interactions, Contraindications
Expert Summary
Across all published fisetin clinical trials to date, no dose-limiting toxicities have been identified at the 20 mg/kg burst dosing protocol. Mild GI symptoms (nausea, loose stools) affect approximately 10% of users at higher doses. Theoretical drug interactions exist with anticoagulants and CYP3A4-metabolized drugs.
Key Facts
- GI symptoms: The most common side effect is mild nausea or loose stools, primarily at doses above 1,000 mg taken without food. Fat co-administration significantly reduces GI symptoms by improving lipid-phase absorption and reducing gut exposure to unabsorbed compound.
- Anticoagulant interaction: Fisetin inhibits platelet aggregation and has mild anticoagulant activity via thromboxane B2 inhibition. Patients on warfarin, heparin, or antiplatelet drugs (aspirin, clopidogrel) should inform their physician before use.
- CYP450 interactions: Fisetin modestly inhibits CYP3A4 and CYP1A2 at high concentrations. This is relevant for drugs with narrow therapeutic windows metabolized by these enzymes (certain statins, immunosuppressants, antiepileptics).
- Pregnancy and lactation: No safety data exists for fisetin use in pregnancy. Given the pro-apoptotic mechanism and potential effects on rapidly dividing fetal cells, fisetin should be avoided during pregnancy and breastfeeding.
- Thyroid considerations: Fisetin has demonstrated weak anti-thyroid activity in animal studies at very high doses. Clinically relevant effects have not been documented at supplemental doses.
- Acute high-dose toxicity: LD50 in mice is >2,000 mg/kg. No hepatotoxicity, nephrotoxicity, or genotoxicity has been observed in standard toxicology panels at supplement-range doses.
Recommended Products
Frequently Asked Questions
Can I take fisetin if I'm on blood thinners?
Use caution and inform your physician. The additive antiplatelet effect of fisetin with anticoagulant drugs creates a theoretical bleeding risk. Dosing adjustments or increased INR monitoring may be warranted.
Is fisetin safe for the kidneys?
Preclinical data is reassuring — fisetin has kidney-protective rather than nephrotoxic effects in most models. Clinical trials in kidney disease (NCT04537702) have not reported adverse renal events.
Can older adults take fisetin at the full 20 mg/kg dose?
Yes. Clinical trials specifically targeting older adults (65+) have used the 20 mg/kg protocol without identifying age-specific safety concerns. Older adults may metabolize fisetin more slowly, potentially prolonging its effects.
Scientific References
- Khan N et al. Fisetin: a dietary antioxidant for health promotion. Antioxidants & Redox Signaling. 2013. PMID: 23373520
- Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. Journal of Internal Medicine. 2020. PMID: 32686219